DCGI Seek Serum Institute Of India Clarification On Oxford COVID-19 Vaccine Trials

Serum Institute of India (SII) has been asked to revise its protocol
for the COVID-19 vaccine trial by a CDSCO panel after they submitted
an application to Drugs Controller General of India (DCGI) requesting
permission for conducting phase 2 and 3 human clinical trials of the
candidate COVID-19 vaccine by Oxford University. A meeting of […]

The post DCGI Seek Serum Institute Of India Clarification On Oxford
COVID-19 Vaccine Trials appeared first on BioTecNika .

https://www.biotecnika.org/2020/07/oxford-vaccine-trial-in-india-dcgi-seek-sii-further-clarification/

Biotech News